This company listing is no longer active
Liminal BioSciences Crecimiento futuro
Future controles de criterios 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Liminal BioSciences.
Información clave
n/a
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 31.0% |
| Tasa de crecimiento de los ingresos | -149.8% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 10 Apr 2023 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | N/A | N/A | N/A | 1 |
| 12/31/2023 | N/A | N/A | N/A | N/A | 1 |
| 12/31/2022 | 0 | -29 | -32 | -32 | N/A |
| 9/30/2022 | 0 | -31 | -38 | -38 | N/A |
| 6/30/2022 | 1 | -35 | -84 | -84 | N/A |
| 3/31/2022 | 0 | -42 | -86 | -86 | N/A |
| 12/31/2021 | 1 | -44 | -100 | -100 | N/A |
| 9/30/2021 | 1 | -48 | -114 | -114 | N/A |
| 6/30/2021 | 1 | -49 | -75 | -74 | N/A |
| 3/31/2021 | 1 | -35 | -75 | -74 | N/A |
| 12/31/2020 | 1 | -48 | -78 | -76 | N/A |
| 9/30/2020 | 1 | -75 | -87 | -85 | N/A |
| 6/30/2020 | 2 | -94 | -86 | -85 | N/A |
| 3/31/2020 | 3 | -232 | -109 | -105 | N/A |
| 12/31/2019 | 1 | -150 | -104 | -99 | N/A |
| 9/30/2019 | -8 | -299 | -95 | -89 | N/A |
| 6/30/2019 | 3 | -298 | -90 | -84 | N/A |
| 3/31/2019 | 23 | -194 | -73 | -68 | N/A |
| 12/31/2018 | 25 | -197 | -88 | -82 | N/A |
| 9/30/2018 | 43 | -131 | -91 | -85 | N/A |
| 6/30/2018 | 55 | -118 | -112 | -105 | N/A |
| 3/31/2018 | 39 | -115 | -128 | -120 | N/A |
| 12/31/2017 | 22 | -112 | -133 | -123 | N/A |
| 9/30/2017 | 37 | -109 | -139 | -129 | N/A |
| 6/30/2017 | 16 | -119 | -130 | -118 | N/A |
| 3/31/2017 | 16 | -112 | -127 | -114 | N/A |
| 12/31/2016 | 16 | -101 | -113 | -98 | N/A |
| 9/30/2016 | 26 | -74 | N/A | -76 | N/A |
| 6/30/2016 | 28 | -58 | N/A | -66 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Insufficient data to determine if PJ2's forecast earnings growth is above the savings rate (0.2%).
Beneficios vs. Mercado: Insufficient data to determine if PJ2's earnings are forecast to grow faster than the German market
Beneficios de alto crecimiento: Insufficient data to determine if PJ2's earnings are expected to grow significantly over the next 3 years.
Ingresos vs. Mercado: PJ2 is forecast to have no revenue next year.
Ingresos de alto crecimiento: PJ2 is forecast to have no revenue next year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if PJ2's Return on Equity is forecast to be high in 3 years time